Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Rossing · SciRah

Researcher profile · Semantic Scholar

P. Rossing

Share profile

P. Rossing — researcher profile on SciRah

h-index: 85
Works: 733
Citations: 47K

Most-cited papers

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
R. Agarwal, Jennifer B. Green, H. Heerspink, J. Mann +11 more
2025New England Journal of Medicine216 citations Open access
Semantic Scholar
The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Susan L. Furth, H. Colhoun, Mehmet Kanbay, Aleksandra Kukla +10 more
2025Kidney International33 citations Open access
Semantic Scholar
COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics
R. Agarwal, Jennifer B. Green, H. Heerspink, J. Mann +11 more
2025Nephrology, Dialysis and Transplantation29 citations Open access
Semantic Scholar
Finerenone Reduces New-Onset Atrial Fibrillation Across the Spectrum of Cardio-Kidney-Metabolic Syndrome: The FINE-HEART Pooled Analysis.
M. Pabón, G. Filippatos, B. Claggett, M. Miao +20 more
2025Journal of the American College of Cardiology29 citations Open access
Semantic Scholar
Impact of Baseline GLP-1 Receptor Agonist Use on Albuminuria Reduction and Safety With Simultaneous Initiation of Finerenone and Empagliflozin in Type 2 Diabetes and Chronic Kidney Disease (CONFIDENCE Trial)
R. Agarwal, J. Green, H. Heerspink, J. Mann +11 more
2025Diabetes Care23 citations Open access
Semantic Scholar
Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis
P. Rossing, G. Bakris, V. Perkovic, R. Pratley +395 more
2025Diabetes Care22 citations Open access
Semantic Scholar
Analysis of the prespecified FIDELITY pooled patient dataset examined the efficacy and safety of finerenone in patients with an acute change in estimated glomerular filtration rate.
S. Navaneethan, S. Anker, G. Filippatos, Bertram Pitt +8 more
2025Kidney International20 citations Open access
Semantic Scholar
Data sharing restrictions are hampering precision health in the European Union
C. Legido-Quigley, N. Wewer Albrechtsen, Martin Bæk Blond, Marcelo Corrales Compagnucci +7 more
2025Nature Medicine15 citations
Semantic Scholar
Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular-Kidney-Metabolic Disease: Pooled Participant-Level Analysis of Three Global Trials.
J. Ostrominski, Josephine L. Harrington, B. Claggett, G. Filippatos +20 more
2025Journal of the American College of Cardiology14 citations Open access
Semantic Scholar
Efficacy and Safety of Finerenone in Heart Failure With Preserved Ejection Fraction: A FINE-HEART Analysis.
J. Ostrominski, G. Filippatos, B. Claggett, Z. Miao +21 more
2025JACC. Heart failure14 citations Open access
Semantic Scholar
Finerenone effects on biomarkers: an analysis from the FIGARO-DKD trial
M. Berger, Aidan MacNamara, J. Ferreira, P. Kolkhof +11 more
2025European Heart Journal14 citations Open access
Semantic Scholar
Polypeptides synthesized by common bacteria in the human gut improve rodent metabolism
Yong Fan, Liwei Lyu, R. Vazquez-Uribe, Wanliang Zhang +24 more
2025Nature Microbiology13 citations Open access
Semantic Scholar
The Steno 1 study: Multifactorial intervention to reduce cardiovascular disease in type 1 diabetes—rationale and protocol of the prospective, randomized, open‐labelled multicentre study
E. Stougaard, M. R. Andersen, Jonatan I. Bagger, Esben Søndergaard +25 more
2025Diabetes, obesity and metabolism12 citations Open access
Semantic Scholar
INCEPT: The Intensive Care Platform Trial—Design and protocol
A. Granholm, M. H. Møller, B. S. Kaas-Hansen, A. Jensen +32 more
2025Acta Anaesthesiologica Scandinavica10 citations Open access
Semantic Scholar
Incident hyperkalaemia risk model in chronic kidney disease and diabetes: the FIDELITY programme.
J. Ferreira, S. Anker, Biff F. Palmer, B. Pitt +9 more
2025European Heart Journal10 citations Open access
Semantic Scholar
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia
R. Agarwal, J. Green, H. Heerspink, J. Mann +13 more
2025American Society of Nephrology. Clinical Journal9 citations Open access
Semantic Scholar
Soluble urokinase plasminogen activator receptor and interleukin‐6 improves prediction of all‐cause mortality and major adverse cardiovascular events in Type 1 diabetes
H. Bahrami, P. Jørgensen, J. D. Hove, U. Dixen +4 more
2025Journal of Internal Medicine9 citations Open access
Semantic Scholar
Efficacy and Safety of Finerenone in Asian Patients with Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis
T. Wada, S. Anker, Zhi-Hong Liu, B. Lee +8 more
2025Kidney Diseases9 citations Open access
Semantic Scholar
Association between interleukin-6, suPAR, and hsCRP with subclinical left ventricular dysfunction in type 1 diabetes: The Thousand & 1 study.
Hashmat Sayed Zohori Bahrami, P. Jørgensen, J. D. Hove, U. Dixen +4 more
2025Diabetes Research and Clinical Practice9 citations Open access
Semantic Scholar
Barriers and new opportunities in developing effective therapies for diabetic neuropathy: International expert consensus recommendations.
C. Brock, H. Andersen, A. Alibegovic, S. Andersen +31 more
2025Diabetes Research and Clinical Practice9 citations Open access
Semantic Scholar
Effect of Once-Weekly Subcutaneous Semaglutide on Arterial Inflammation in People with Type 2 Diabetes and Cardiovascular Disease Using PET-MRI: Primary Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
S. James, Andreas D. Christoffersen, J. David, M. Hacker +7 more
2025American Heart Journal8 citations Open access
Semantic Scholar
GLP-1 receptor agonists and other incretin mimetics for diabetes and chronic kidney disease-a KDIGO commentary.
I. D. de Boer, M. L. Caramori, Juliana C. N. Chan, H. Heerspink +12 more
2025Kidney International8 citations Open access
Semantic Scholar
Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial
M. Vaduganathan, Jennifer B. Green, H. Heerspink, Sung Gyun Kim +11 more
2025Nephrology, Dialysis and Transplantation8 citations Open access
Semantic Scholar
Genetic factors shaping the plasma lipidome and the relations to cardiometabolic risk in children and adolescents
Yun Huang, S. E. Stinson, M. Thodberg, L. Holm +14 more
2025EBioMedicine8 citations Open access
Semantic Scholar
Kidney and Survival Outcomes with Semaglutide by CKD Severity in the FLOW Trial
Katherine R. Tuttle, J. Mann, Manuel Mayrdorfer, B. Rayner +12 more
2026American Society of Nephrology. Clinical Journal7 citations Open access
Semantic Scholar
Cumulative risk of diabetic foot complications in risk groups of type 1 and type 2 diabetes: Real‐world evidence from a 22‐year follow‐up study
Abhilasha Akerkar, P. F. Rønn, Vanja Kosjerina, C. S. Hansen +5 more
2025Diabetes, obesity and metabolism7 citations Open access
Semantic Scholar
Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials of Heart Failure and Chronic Kidney Disease.
J. Ostrominski, B. Claggett, Z. Miao, G. Filippatos +21 more
2025Diabetes Care7 citations Open access
Semantic Scholar
Characterization of Anti-Insulin Antibodies in Type 1 and Type 2 Diabetes Mellitus: Clinical Relevance
Henrik Toft-Hansen, Christina Aniol-Nielsen, Daniel Elias, M. Dahlbäck +6 more
2025International Journal of Molecular Sciences7 citations Open access
Semantic Scholar
Efficacy and hypoglycaemia outcomes with once‐weekly insulin icodec versus once‐daily basal insulin in individuals with type 2 diabetes by kidney function: A post hoc participant‐level analysis of the ONWARDS 1–5 trials
P. Rossing, M. Benamar, Alice Y Y Cheng, Bharath Kumar +2 more
2025Diabetes, obesity and metabolism7 citations Open access
Semantic Scholar
Sex differences in myocardial flow reserve among individuals with type 2 diabetes: insights from the DiaHeart study
Anne-Cathrine Skriver-Møller, P. Hasbak, I. Rasmussen, M. B. Blond +13 more
2025Cardiovascular Diabetology7 citations Open access
Semantic Scholar
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025
Stefan D. Anker, Li-Nong Ji, Tammy Kindel, A. Coats +57 more
2026Journal of Cachexia, Sarcopenia and Muscle6 citations Open access
Semantic Scholar
Comparing CKD populations with T1D and T2D: a perspective based on the FINE-ONE and FIDELITY populations.
H. Heerspink, R. Agarwal, Antonio J. Amor, J. Bech +14 more
2025Nephrology, Dialysis and Transplantation6 citations Open access
Semantic Scholar
Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non‐diabetic chronic kidney disease
Victor S. Wasehuus, J. D. Smeijer, Phil Ambery, P. Greasley +4 more
2025Diabetes, obesity and metabolism6 citations Open access
Semantic Scholar
Effect of Finerenone on Morbidity and Mortality in CKD
J. Ostrominski, G. Filippatos, B. Claggett, Z. Miao +20 more
2025Journal of the American Society of Nephrology6 citations Open access
Semantic Scholar
Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both
A. Mottl, Charlie Scott, J. Green, H. Heerspink +9 more
2025Journal of the American Society of Nephrology5 citations Open access
Semantic Scholar
In silico prediction of optimal multifactorial intervention in chronic kidney disease
A. Latosinska, I. Mina, T. Nguyen, I. Golovko +18 more
2025Journal of Translational Medicine5 citations Open access
Semantic Scholar
Cardiac Effects of Dapagliflozin in People with Chronic Kidney Disease.
K. Bartholdy, N. Johansen, K. Skaarup, D. Modin +25 more
2025NEJM Evidence5 citations
Semantic Scholar
Joslin Kidney Panel of circulating proteins: a tool for ESKD risk discrimination and individualized diabetic kidney disease treatment
A. Krolewski, J. Haukka, Zaipul I. Md Dom, V. R. Curovic +23 more
2025American Society of Nephrology. Clinical Journal5 citations Open access
Semantic Scholar
Targeting visceral and ectopic adiposity: Pharmacological and surgical interventions beyond global weight loss
Mustafa Guldan, Laşin Ozbek, S. Abdel-Rahman, Arif E. Narin +5 more
2025Diabetes, obesity and metabolism4 citations
Semantic Scholar
Genome-Wide Association Study of Quantitative Kidney Function in 52,531 Individuals with Diabetes Identifies Five Diabetes-Specific Loci.
Joanne B. Cole, E. Dahlström, D. Fermin, Yogesh Gupta +48 more
2025Journal of the American Society of Nephrology4 citations Open access
Semantic Scholar
Metabolomic risk predictors of diabetic foot complications: A longitudinal observational study in type 1 diabetes
J. Andersen, T. Suvitaival, Kajetan Trošt, M. J. Romero-Lado +7 more
2025Diabetes, obesity and metabolism3 citations Open access
Semantic Scholar
Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index
P. Rossing, A. Birkenfeld, P. Fioretto, J. McGill +7 more
2025American Society of Nephrology. Clinical Journal3 citations Open access
Semantic Scholar
Trends in nephrology: From "diabetic kidney disease" to "CKD with risk factor diabetes".
M. Speeckaert, P. Rossing
2025Nephrology, Dialysis and Transplantation3 citations Open access
Semantic Scholar
Finerenone Efficacy in Patients with Chronic Kidney Disease, Type 2 Diabetes, and Anemia in FIDELITY
Ajay K. Singh, G. James, S. Anker, Bertram Pitt +6 more
2025JACC: Advances3 citations Open access
Semantic Scholar
A Hierarchical Composite Endpoint for Chronic Kidney Disease Progression in Patients with Focal Segmental Glomerulosclerosis.
H. Heerspink, Dustin J. Little, S. Gasparyan, Glenn M. Chertow +6 more
2026American Society of Nephrology. Clinical Journal2 citations Open access
Semantic Scholar
Exome-Wide Analysis Identifies a Rare EXD3 Missense Variant Associated With Diabetic Kidney Disease
N. Sandholm, Joanne B. Cole, V. Nair, E. Brennan +35 more
2025Kidney International Reports2 citations Open access
Semantic Scholar
Current advances in diabetic neuropathy: Proteins as therapeutic targets
G. Kaur, S. Ali, Alberto Santos, T. Okdahl +11 more
2025iScience2 citations Open access
Semantic Scholar
Infective endocarditis and relationship with diabetes mellitus - Patient characteristics, microbial etiology and mortality
A. Jensen, L. Østergaard, P. Graversen, K. Hadji-Turdeghal +8 more
2025Infection2 citations Open access
Semantic Scholar
Trends in use of cardiorenal protective medication among people with type 2 diabetes and chronic kidney disease in Denmark
R. Rørth, T. A. Gerds, Vanja Kosjerina, Bendix Carstensen +2 more
2025Diabetes Epidemiology and Management2 citations Open access
Semantic Scholar
Efficacy and safety of finerenone in Asian patients with type 2 diabetes and chronic kidney disease: A FIDELITY analysis by baseline kidney function.
Shigehiro Katayama, S. Anker, D. Zhu, Sung-Gwon Kim +10 more
2025Journal of diabetes and its complications2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Brinker×13
Invite
M. Brinker — researcher profile on SciRah
R. Agarwal×12
Invite
R. Agarwal — researcher profile on SciRah
H. Heerspink×11
Invite
H. Heerspink — researcher profile on SciRah
M. Vaduganathan×11
Invite
M. Vaduganathan — researcher profile on SciRah

×11

Invite

S. Anker — researcher profile on SciRah

G. Filippatos×10

Invite

G. Filippatos — researcher profile on SciRah

Invite

J. McGill — researcher profile on SciRah

Charlie Scott×8

Invite

Charlie Scott — researcher profile on SciRah

K. Rohwedder×8

Invite

K. Rohwedder — researcher profile on SciRah

Invite

F. Zannad — researcher profile on SciRah

Invite

L. Ruilope — researcher profile on SciRah

J. Rosenstock×6

Invite

J. Rosenstock — researcher profile on SciRah